Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

ClinicalTrials.gov ID: NCT03568331

Public ClinicalTrials.gov record NCT03568331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Efficacy Study of The Neurokinin-1 Receptor Antagonist VLY-686 in Patients With Atopic Dermatitis

Study identification

NCT ID
NCT03568331
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
375 participants

Conditions and interventions

Interventions

  • Tradipitant Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 8, 2018
Primary completion
Dec 26, 2019
Completion
Dec 26, 2019
Last update posted
May 12, 2024

2018 – 2019

United States locations

U.S. sites
70
U.S. states
30
U.S. cities
63
Facility City State ZIP Site status
Vanda Investigational Site Birmingham Alabama 35224
Vanda Investigational Site Birmingham Alabama 35233
Vanda Investigational Site Tempe Arizona 85283
Vanda Investigational Site Encino California 91436
Vanda Investigational Site Fountain Valley California 92708
Vanda Investigational Site Fremont California 94538
Vanda Investigational Site Laguna Hills California 92653
Vanda Investigational Site Lomita California 90717
Vanda Investigational Site Long Beach California 90806
Vanda Investigational Site Los Angeles California 90017
Vanda Investigational Site Los Angeles California 90036
Vanda Investigational Site San Diego California 92122
Vanda Investigational Site Santa Monica California 90404
Vanda Investigational Site Denver Colorado 80220
Vanda Investigational Site Aventura Florida 33180
Vanda Investigational Site Clearwater Florida 33756
Vanda Investigational Site Fort Lauderdale Florida 33306
Vanda Investigational Site Hialeah Florida 33016
Vanda Investigational Site Miami Florida 33126
Vanda Investigational Site Miami Florida 33137
Vanda Investigational Site Miramar Florida 33027
Vanda Investigational Site Ormond Beach Florida 32174
Vanda Investigational Site South Miami Florida 33143
Vanda Investigational Site Tampa Florida 33613
Vanda Investigational Site Savannah Georgia 31406
Vanda Investigational Site Boise Idaho 83704
Vanda Investigational Site Normal Illinois 61761
Vanda Investigational Site Skokie Illinois 60077
Vanda Investigational Site Plainfield Indiana 46168
Vanda Investigational Site Crowley Louisiana 70526
Vanda Investigational Site Rockville Maryland 20850
Vanda Investigational Site Towson Maryland 21204
Vanda Investigational Site Beverly Massachusetts 01915
Vanda Investigational Site Brighton Massachusetts 02135
Vanda Investigational Site Fort Gratiot Michigan 48059
Vanda Investigational Site Saint Joseph Missouri 64506
Vanda Investigational Site St Louis Missouri 63141
Vanda Investigational Site Omaha Nebraska 68144
Vanda Investigational Site Las Vegas Nevada 89106
Vanda Investigational Site Las Vegas Nevada 89119
Vanda Investigational Site Berlin New Jersey 08009
Vanda Investigational Site Verona New Jersey 07044
Vanda Investigational Site Brooklyn New York 11201
Vanda Investigational Site New York New York 10003
Vanda Investigational Site New York New York 10022
Vanda Investigational Site New York New York 10075
Vanda Investigational Site Charlotte North Carolina 28277
Vanda Investigational Site High Point North Carolina 27262
Vanda Investigational Site Wilmington North Carolina 28405
Vanda Investigational Site Cincinnati Ohio 45212
Vanda Investigational Site Dayton Ohio 45414
Vanda Investigational Site Oklahoma City Oklahoma 73112
Vanda Investigational Site Tulsa Oklahoma 74136
Vanda Investigational Site Philadelphia Pennsylvania 19104
Vanda Investigational Site Pittsburgh Pennsylvania 15213
Vanda Investigational Site Johnston Rhode Island 02919
Vanda Investigational Site North Charleston South Carolina 29420
Vanda Investigational Site Spartanburg South Carolina 29301
Vanda Investigational Site Chattanooga Tennessee 37421
Vanda Investigational Site Nashville Tennessee 37211
Vanda Investigational Site Dallas Texas 75230
Vanda Investigational Site Pflugerville Texas 78660
Vanda Investigational Site San Antonio Texas 78213
Vanda Investigational Site San Antonio Texas 78218
Vanda Investigational Site West Jordan Utah 84088
Vanda Investigational Site South Burlington Vermont 05403
Vanda Investigational Site Newport News Virginia 23606
Vanda Investigational Site Norfolk Virginia 23507
Vanda Investigational Site Richmond Virginia 23233
Vanda Investigational Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03568331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03568331 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →